alexa Expression of Silent Information Regulator-1(Sirt1), CD
ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Expression of Silent Information Regulator-1(Sirt1), CD163 and Tryptase; Implications for Immune Dys-regulation, Prognosis and Therapeutic Targeting in Classical Hodgkin Lymphoma

Harb OA1*, Mohamed MS1, Ahmed RZ2, Alattar AZ3 and Gertallah LM4

1Department of Pathology, Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt

2Department of Medical Oncology, Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt

3Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt

4Department of General Surgery, Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt

*Corresponding Author:
Ola Harb
Department of Pathology, Faculty of Medicine
Zagazig University, Zagazig 44519, Egypt
Tel: 01224963123
E-mail: [email protected]

Received date: May 27, 2017; Accepted date: June 20, 2017; Published date: June 26, 2017

Citation: Harb OA, Mohamed MS, Ahmed RZ, Alattar AZ, Gertallah LM (2017) Expression of Silent Information Regulator-1 (Sirt1), CD163 and Tryptase; Implications for Immune Dys-regulation, Prognosis and Therapeutic Targeting in Classical Hodgkin Lymphoma. J Clin Exp Pathol 7:313. doi: 10.4172/2161-0681.1000313

Copyright: © 2017 Harb OA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Background: Many studies have assessed the relation between cHL histology and its clinical outcome but the results are still controversial. The most recent issue was the discovery of the methods of interaction between the elements of benign reactive inflammatory cells and their effect on cHL metabolism. Silent information regulator-1 (Sirt1) is a class III HDACs family member, it was expressed in T-cell lymphoma and was considered a recently discovered therapeutic target, we tried to detect that the significance of Sirt1 expression in malignant Reed-Sternberg cells and surrounding inflammatory infiltrate in cHL. Cluster of Differentiation 163 (CD163) is a scavenger receptor cystein-rich (SRCR) family member which identifies monocytes and macrophages, Tryptase is the secretory granules that were serine proteinase derived and it has been used as a mast cell activation marker. The tumor-infiltrating macrophages and mast cells have been found to have different roles in malignancies of many organs but their role in cHL prognosis had not been sufficiently clarified.

Aim of the work: To assess the influence of Sirt1 expression in the malignant cells and the surrounding tumor microenvironment CD163 positive macrophages and tryptase positive mast cells on the pathological parameters and clinical outcome in cHL patients.

Methods: We evaluated clinicopathological and prognostic significance of Sirt1, CD163 and tryptase expressions in sections from fifty paraffin blocks of cHL using immunehistochemistry.

Results: The expression of Sirt1 in cHL was associated with advanced stage of the disease, presence of B symptoms, splenic affection, (p<0.001), bone marrow infiltration (p=0.002) and the presence of bulky mediastinal lymph node (p=0.004). The expression of CD163 and tryptase in cHL was associated with advanced stage of the disease and the presence of bulky mediastinal lymph node (p<0.001). High Sirt1, tryptase and CD163 expression was associated with poor response to therapy, high incidence of relapse after successful therapy and poor three-year overall survival rate (p<0.001).

Conclusion: High levels of expression of Sirt1, CD163 and tryptase were found to be markers of poor prognosis in cHL.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords